This compound is a pharmaceutical intermediate used in the synthesis of bexarotene impurities. It features a substituted naphthalene ring system with an ethenyl-linked phenyl ethanone group, giving it a rigid, aromatic structure with moderate polarity.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1349659-53-5
Bexarotene
antioneoplastic active pharmaceutical ingredient
Methyl 4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoate
Bexarotene impurity reference standard
2-[2-(2-aminoethoxy)ethoxy]acetic acid;hydrochloride
Pharmaceutical intermediate for pegylation
(1S,5R)-8-Methyl-8-Azabicyclo(3.2.1)Octan-3-Ol
pharmaceutical intermediate
Dibenzyl (2S,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate
protected proline derivative for peptide synthesis
Febuxostat impurity 7
Pharmaceutical impurity reference standard
1-[4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]phenyl]ethanone
SJDZRZNTLQWQAH-UHFFFAOYSA-N
CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)C)C(CCC2(C)C)(C)C
—